These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

312 related items for PubMed ID: 21839625

  • 1. Ciclesonide in wheezy preschool children with a positive asthma predictive index or atopy.
    Brand PL, Luz García-García M, Morison A, Vermeulen JH, Weber HC.
    Respir Med; 2011 Nov; 105(11):1588-95. PubMed ID: 21839625
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Once-daily ciclesonide improves lung function and is well tolerated by patients with mild-to-moderate persistent asthma.
    Pearlman DS, Berger WE, Kerwin E, Laforce C, Kundu S, Banerji D.
    J Allergy Clin Immunol; 2005 Dec; 116(6):1206-12. PubMed ID: 16337447
    [Abstract] [Full Text] [Related]

  • 4. Comparison of the efficacy and safety of ciclesonide 160 microg once daily vs. budesonide 400 microg once daily in children with asthma.
    von Berg A, Engelstätter R, Minic P, Sréckovic M, Garcia Garcia ML, Latoś T, Vermeulen JH, Leichtl S, Hellbardt S, Bethke TD.
    Pediatr Allergy Immunol; 2007 Aug; 18(5):391-400. PubMed ID: 17617808
    [Abstract] [Full Text] [Related]

  • 5. A multinational, 12-week, randomized study comparing the efficacy and tolerability of ciclesonide and budesonide in patients with asthma.
    Hansel TT, Benezet O, Kafé H, Ponitz HH, Cheung D, Engelstätter R, Barnes PJ.
    Clin Ther; 2006 Jun; 28(6):906-20. PubMed ID: 16860173
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of three ciclesonide doses vs placebo in children with asthma: the RAINBOW study.
    Pedersen S, Potter P, Dachev S, Bosheva M, Kaczmarek J, Springer E, Dunkel J, Engelstätter R.
    Respir Med; 2010 Nov; 104(11):1618-28. PubMed ID: 20619624
    [Abstract] [Full Text] [Related]

  • 7. Maintenance of asthma control by once-daily inhaled ciclesonide in adults with persistent asthma.
    Chapman KR, Patel P, D'Urzo AD, Alexander M, Mehra S, Oedekoven C, Engelstätter R, Boulet LP.
    Allergy; 2005 Mar; 60(3):330-7. PubMed ID: 15679718
    [Abstract] [Full Text] [Related]

  • 8. A 24-week comparison of low-dose ciclesonide and fluticasone propionate in mild to moderate asthma.
    Dahl R, Engelstätter R, Trebas-Pietraś E, Kuna P.
    Respir Med; 2010 Aug; 104(8):1121-30. PubMed ID: 20430601
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Randomized comparison of ciclesonide 160 and 640 microg/day in severe asthma.
    Bateman ED, Cheung D, Lapa e Silva J, Göhring UM, Schäfer M, Engelstätter R.
    Pulm Pharmacol Ther; 2008 Aug; 21(3):489-98. PubMed ID: 18178494
    [Abstract] [Full Text] [Related]

  • 12. Randomized comparison of the efficacy and safety of ciclesonide and budesonide in adolescents with severe asthma.
    Vermeulen JH, Gyurkovits K, Rauer H, Engelstätter R.
    Respir Med; 2007 Oct; 101(10):2182-91. PubMed ID: 17614270
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of once-daily inhaled ciclesonide in adults with mild to moderate asthma: a double-blind, placebo-controlled study.
    Adachi M, Ishihara K, Inoue H, Kudo K, Takahashi K, Morita Y, Masuda K, Takada Y, Kato R, Miyamoto T.
    Respirology; 2007 Jul; 12(4):566-72. PubMed ID: 17587424
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and safety of ciclesonide in patients with severe asthma: a 12-week, double-blind, randomized, parallel-group study with long-term (1-year) follow-up.
    O'Connor BJ, Kilfeather S, Cheung D, Kafé H, Blagden MD, Schlösser N, Ayres JG, Weber HJ, Engelstätter R.
    Expert Opin Pharmacother; 2010 Dec; 11(17):2791-803. PubMed ID: 20958119
    [Abstract] [Full Text] [Related]

  • 15. Similar efficacy of ciclesonide versus prednisolone to treat asthma worsening after steroid tapering.
    van den Berge M, Arshad SH, Ind PW, Magnussen H, Hamelmann E, Kanniess F, Postma DS.
    Respir Med; 2009 Aug; 103(8):1216-23. PubMed ID: 19297141
    [Abstract] [Full Text] [Related]

  • 16. Once-daily ciclesonide 80 or 320 microg for 12 weeks is safe and effective in patients with persistent asthma.
    Langdon CG, Adler M, Mehra S, Alexander M, Drollmann A.
    Respir Med; 2005 Oct; 99(10):1275-85. PubMed ID: 16024244
    [Abstract] [Full Text] [Related]

  • 17. Once-daily ciclesonide via metered-dose inhaler: Similar efficacy and safety with or without a spacer.
    Engelstätter R, Szlávik M, Gerber C, Beck E.
    Respir Med; 2009 Nov; 103(11):1643-50. PubMed ID: 19596188
    [Abstract] [Full Text] [Related]

  • 18. Comparative efficacy of once-daily ciclesonide and budesonide in the treatment of persistent asthma.
    Boulet LP, Drollmann A, Magyar P, Timar M, Knight A, Engelstätter R, Fabbri L.
    Respir Med; 2006 May; 100(5):785-94. PubMed ID: 16427266
    [Abstract] [Full Text] [Related]

  • 19. A randomized study comparing ciclesonide and fluticasone propionate in patients with moderate persistent asthma.
    Boulet LP, Bateman ED, Voves R, Müller T, Wolf S, Engelstätter R.
    Respir Med; 2007 Aug; 101(8):1677-86. PubMed ID: 17448650
    [Abstract] [Full Text] [Related]

  • 20. Ciclesonide improves measures of small airway involvement in asthma.
    Cohen J, Douma WR, ten Hacken NH, Vonk JM, Oudkerk M, Postma DS.
    Eur Respir J; 2008 Jun; 31(6):1213-20. PubMed ID: 18287130
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.